Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Priothera Appoints Nigel Clark As Chief Business Officer

PRIVATESep 03, 20263 days ago

Position

Chief Business Officer

Company

Priothera

Nigel Clark
Saint-LouisBiotechnologyHealth CareTherapeuticsBiopharma

Description

Priothera has announced the appointment of Nigel Clark, PhD, as Chief Business Officer (CBO). Dr. Clark brings over 25 years of experience in commercial and strategic leadership within the biotechnology and pharmaceutical industries.

Company Information

Company

Priothera

Location

Saint-Louis, Grand Est, France

About

Priothera is a late-stage biopharma company pioneering the development of mocravimod, a potential new standard of care in hematologic cancers. The company focuses on adjunctive and maintenance therapy for hematological malignancies, particularly acute myeloid leukemia (AML). They aim to improve patients’ quality of life and outcomes with innovative treatments.

Don't miss Priothera's next move

Get an email the moment Priothera changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Jens
Likely contact at this company
••••••••@••••••••

See Jens's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Priothera's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Priothera changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.